1.
Less veno-occlusive disease after intravenous versus oral busulfan for autologous haematopoietic stem cell transp.l antation: the Belgian paediatric experlence
2.
3.
4.
An estimation of the incidence and demographic picture of the major hemoglobinopathies in Belgium (from a confidential inquiry)
Hydroxyurea for sickle cell disease in children and for prevention of cerebrovascular events: the Belgian experience.